Preferential concentration of azithromycin in an infected mouse thigh model

J A Retsema1, J M Bergeron, D Girard

  • 1Central Research Division, Pfizer Inc, Groton, CT 06340.

Insights

Azithromycin delivery to infection sites is enhanced by inflammation, particularly by polymorphonuclear leucocytes. This increased concentration in infected tissues leads to better bacterial clearance in Staphylococcus aureus models.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Azithromycin is a macrolide antibiotic used to treat bacterial infections.
  • Understanding drug delivery to infection sites is crucial for optimizing antimicrobial therapy.
  • Inflammatory processes can influence the pharmacokinetic properties of antibiotics.

Purpose of the Study:

  • To evaluate the augmentation of azithromycin delivery to infection loci.
  • To investigate the role of inflammation and cellular infiltration in azithromycin concentration at infection sites.
  • To compare azithromycin's tissue distribution with other macrolides in an infection model.

Main Methods:

  • Utilized Staphylococcus aureus thigh infection models in CD-1 mice.
  • Assessed bacterial growth, edema formation (gravimetrically), and polymorphonuclear leucocyte infiltration.
  • Quantified azithromycin concentrations in infected and non-infected tissues at various time points post-infection and dosing.

Main Results:

  • Azithromycin concentrations were significantly enhanced in infected thigh tissues compared to non-infected tissues.
  • Enhanced azithromycin levels correlated with edema and bacterial load, particularly between 24-72 hours.
  • Delayed azithromycin administration during more severe inflammation resulted in even greater preferential concentration.

Conclusions:

  • Cellular inflammatory processes, specifically polymorphonuclear leucocyte infiltration, enhance the delivery of biologically available azithromycin to infected tissues.
  • The concentration of azithromycin in infected tissues was sufficient to reduce bacterial counts (cfu).
  • Other macrolides like erythromycin, roxithromycin, and clarithromycin did not show preferential concentration in infected tissues under similar conditions.

Related Concept Videos